News Articles
Showing 6766 News Articles-
Jan 26, 2022
Filament Health
-
Seattle Legalizes Psychedelics
Jan 25, 2022 – Proponents of the legalization of psychedelics has won a victory. ... Monday to decriminalize a wide range of activities around psychedelic drugs, ...
Psilocybin / Mescaline / Ibogaine / Ayahuasca / Iboga
-
MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022
Jan 25, 2022
-
G2 Buys Peyote-Focused Psychedelics Company Lophos Pharma | Benzinga
Jan 24, 2022 – Greenridez 2.0 Acquisitions Corp. confirmed Friday that it has completed its acquisition of psychedelic research company.
-
Cover Story: Power Trip: New York Magazine podcast investigates psychedelics | Stuff.co.nz
Jan 22, 2022 – More than ever, people are turning to psychedelics for relief, enlightenment and understanding – think ayahuasca retreats and mushroom ...
Ayahuasca
-
Have You Taken Psychedelics? Participate In The Canadian Psychedelics Survey ...
Jan 21, 2022 – ... MDMA, ayahuasca, and ketamine, as well as whether participants have ever used certain psychedelics in combination with other drugs.
MDMA / Ketamine / Ayahuasca / Psilocybin
-
G2 Acquires Lophos Pharma, a peyote focused psychedelics company - GlobeNewswire
Jan 21, 2022 – Lophos Pharma is a psychedelic research company primarily focused on novel therapeutic treatments derived from Peyote (Lophophora williamsii).
-
Do Ayahuasca Healing Ceremonies Really Work? | Psychology Today
Jan 18, 2022 – In some cases an ayahuasca ceremony may be more effective for treating neuroticism than traditional therapies. Six percent of study participants ...
Ayahuasca
-
Terminally Ill Patients In Missouri Can Seek Psychedelic Treatments Under 'Right To Try ...
Jan 15, 2022 – ... participating in the right-to-try policy to possess Schedule I drugs such as MDMA, DMT, ibogaine, LSD, mescaline, peyote and psilocybin.
Psilocybin / LSD / Mescaline / DMT / MDMA / Ibogaine / Iboga
-
Wesana Health Provides Strategic and Operational Updates
Jan 12, 2022
Wesana Health
-
Jan 12, 2022
Pharmather
-
Jan 12, 2022
MYND Life Sciences Inc.
-
Jan 12, 2022
atai Life Sciences
-
Wesana Health Granted US FDA Pre-IND Meeting for SANA-013
Jan 11, 2022
Wesana Health
-
$14.8 million for innovative mental health clinical trials
Jan 07, 2022
-
Jan 06, 2022
Field Trip Health
-
Oct 20, 2021
COMPASS Pathways
-
Mycrodose Therapeutics and Nova Mentis Announce LOI to Co-Develop Advanced Drug Delivery System
Oct 19, 2021
-
Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies
Oct 19, 2021
-
Oct 19, 2021
atai Life Sciences
-
Johns Hopkins Medicine Receives First Federal Grant for Psychedelic Treatment Research in 50 years
Oct 18, 2021
Johns Hopkins University
-
Oct 14, 2021
Alto Neuroscience
-
Novamind Granted DEA Licenses for Psilocybin Research
Oct 13, 2021
-
Negev Capital Invests in Production and Distribution of Artisanal Functional Mushrooms
Oct 12, 2021
-
Psygen Announces That Psilocybin from Its Patent-Pending Process Has Been Used in Human Trial
Oct 06, 2021
-
Oct 06, 2021
-
Universal Ibogaine Commences Trading on the TSX-V
Oct 05, 2021
Universal Ibogaine
-
Oct 05, 2021
-
Lobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI and PTSD
Oct 04, 2021
-
Awakn Life Sciences acquires Exclusive Rights To MDMA Research From Imperial College London
Sep 23, 2021
Awakn Life Sciences, Inc.
-
Enveric Biosciences Announces Closing of MagicMed Industries Acquisition
Sep 17, 2021
-
Awakn Life Sciences to Acquire Leading Ketamine-assisted Psychotherapy Clinic in Norway
Sep 16, 2021
Awakn Life Sciences, Inc.
-
Sep 14, 2021
atai Life Sciences
-
Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine
Sep 13, 2021
Cannabics Pharmaceuticals
-
Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds
Sep 10, 2021
COMPASS Pathways
-
Novamind Uplists to OTCQB Venture Market
Sep 09, 2021
Novamind
-
Sep 09, 2021
Field Trip Health
-
CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development
Sep 08, 2021
CaaMTech
-
Sep 07, 2021
Journey Colab
-
Sep 01, 2021
-
TheraPsil Launches Beta Version of Health Canada Approved Psilocybin Therapy Training Program
Mar 02, 2021
TheraPsil
-
BIG PHARMA Stroke Victims to Be Given Psychedelic Drug DMT in First-Ever US Clinical Trials
Feb 27, 2021
-
NYU Langone Health Establishes Center for Psychedelic Medicine
Feb 25, 2021
NYU Langone Health
-
Psychedelic drug DMT to be trialled in UK to treat depression
Jan 15, 2021
-
UFC looks into Johns Hopkins study on psychedelic drugs as potential therapy for fighters
Jan 14, 2021
-
Remembering Psychedelic Activist and Drug Policy Pioneer Sheri Eckert, 1961-2020
Dec 23, 2020
Lucid News
-
Canada Is Allowing People With Depression to Do Psychedelic Mushrooms
Nov 17, 2020
-
Nov 12, 2020
-
Psychedelic Treatment with Psilocybin Relieves Major Depression, Study Shows
Nov 04, 2020
Johns Hopkins University
-
Why Doctors Are Turning to Psychedelics to Treat Depression and Addiction
Oct 26, 2020